BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee C, Bhakta S. The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review. Antibiotics (Basel) 2021;10:91. [PMID: 33477812 DOI: 10.3390/antibiotics10010091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Khoza LJ, Kumar P, Dube A, Demana PH, Choonara YE. Insights into Innovative Therapeutics for Drug-Resistant Tuberculosis: Host-Directed Therapy and Autophagy Inducing Modified Nanoparticles. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121893] [Reference Citation Analysis]
2 Daniel C, Bhakta S. Immunobiology of tubercle bacilli and prospects of immunomodulatory drugs to tackle tuberculosis (TB) and other non-tubercular mycobacterial infections. Immunobiology 2022;227:152224. [DOI: 10.1016/j.imbio.2022.152224] [Reference Citation Analysis]
3 Lee C, Lin J, Prokop A, Gopalakrishnan V, Hanna RN, Papa E, Freeman A, Patel S, Yu W, Huhn M, Sheikh AS, Tan K, Sellman BR, Cohen T, Mangion J, Khan FM, Gusev Y, Shameer K. StarGazer: A Hybrid Intelligence Platform for Drug Target Prioritization and Digital Drug Repositioning Using Streamlit. Front Genet 2022;13:868015. [PMID: 35711912 DOI: 10.3389/fgene.2022.868015] [Reference Citation Analysis]
4 Daley SK, Cordell GA. Alkaloids in Contemporary Drug Discovery to Meet Global Disease Needs. Molecules 2021;26:3800. [PMID: 34206470 DOI: 10.3390/molecules26133800] [Reference Citation Analysis]